Drugs Controller General Dr. Rajeev Raghuvanshi Highlights Digital Shift in Blood Bank Licensing

By A Staff Reporter

DELHI: In a significant step towards improving efficiency, Drugs Controller General of India (DCGI) Dr. Rajeev Raghuvanshi announced the complete digitalization of the blood banking licensing process, drastically reducing approval timelines. Speaking at a press conference, Dr. Raghuvanshi explained, "Earlier, the blood banking licensing used to happen on the physical file. It used to take a lot of time. Now, we have completely made it digital, which has reduced the timeline for the approval of blood banks."

The move to a digital system aims to streamline operations and enhance the efficiency of regulatory processes in the health sector, particularly in critical areas like blood bank approvals.

Dr. Raghuvanshi also highlighted the improvements in the regulation of pharmaceutical products such as cough syrups, stating, "Since cough syrups were also products which were regulated, the system has been improved and has become very vigilant."

He further elaborated on the steps taken to ensure product safety, mentioning the tracking of supply chains for special solvents used in manufacturing. "We tracked down the supply chain of the special solvent and took strict action on the non-compliant dealers," he said, emphasizing the government's commitment to maintaining high standards of compliance and accountability in the industry.

This move towards digitization, along with stricter vigilance and enforcement, underscores the ongoing efforts by the DCGI to improve transparency and safety within the pharmaceutical and healthcare sectors.